Declaration of occupational disease linked to Covid-19

EXPERT ARTICLE - By Samia Benmahrez, Consultant HR performance, at GAC Group

Your employee has contracted an illness related to COVID-19 as part of his professional activity?

An online service " »Is made available to employees (or beneficiaries) who wish to apply for recognition of occupational disease. Objective: to benefit from support under professional legislation.

Which employees are affected?

  • Employees who do not work in the health sector can apply for recognition as an occupational disease under 2 conditions:
    • If they contracted Covid-19 in the course of their work
    • What if the disease has resulted in serious illness.

A committee of medical experts will examine their request.

  • Employees working in the health sector may benefit from recognition under the following conditions:
    • Their contamination with Covid-19 took place in the course of their work
    • Their contamination with Covid-19 has also led to a serious respiratory disease with recourse to oxygen therapy or any other form of respiratory assistance.

If it is a serious condition other than respiratory, a committee of medical experts will first examine their request for recognition.


What is the support?

The recognition as an occupational disease allows compensation for care at 100% rates reimbursable by social security. It also allows daily allowances more advantageous than sickness for employees.

In the event of sequelae causing permanent disability, the employee may receive an annuity. These are the seriousness of the sequelae and the income prior to the contraction of the virus allow its calculation. .

For your information, the beneficiaries of an employee who died due to the COVID-19 disease can also apply on the dedicated platform and benefit from an annuity.


What are the documents to provide?

To make their request online, the employee must provide:

  • A " initial medical certificate»(CMI) established by his attending physician. He makes the diagnosis of COVID-19 and mentions the clinical elements or examinations that led him to make this diagnosis.
  • A hospital report which mentions the use of oxygen therapy and the COVD-19 diagnosis. If the oxygen therapy was performed outside a hospital setting, the attending physician should include this information in the CMI.
  • Be a proof of professional activity be one employer's certificate. These must mention the job, the periods of absence in 2020 and attesting to contact with the public.
  • For the beneficiaries of the employee who died due to the COVID-19 infection, in addition to the documents requested above, it will be necessary to provide a copy of the family record book of the deceased.


It is important to remember that the statements made on the online service do not constitute recognition of the professional nature of the Covid-19 infection. This is done after verification by the Caisse Primaire d'Assurance Maladie (CPAM) services in accordance with the legislation in force on occupational risk.

Upon receipt of the request, the CPAM will study it and discuss it with the employee to complete his file.

At the end of this procedure, the CPAM will send the employee a registered letter. The latter informing him of the completion and start of the examination phase of his file and of the stages of the procedure to come.

The CPAM must also inform the employer of the examination of the occupational disease file.


Please do not hesitate to contact us if you have any questions on the subject.


To not miss any news on this subject, do not hesitate to subscribe to our HR Newsletter.

Share on facebook
Share on twitter
Share on linkedin
Share on email

Articles in Relationship

Le Crédit Impôt Recherche allemand : la nouvelle prime fiscale à la R&D

The German Research Tax Credit: the new R&D tax premium! October 1, 2021

Take part in our webinar which will take place on Friday October 1, 2021 from 11:30 am Since March 2021, Germany has fully implemented the new tax bonus system for industrial R&D. With this new funding program, the German government has set itself an ambitious goal of supporting innovation with a budget

The 8th edition of the competition opened on July 29, 2021 and will close on October 5, 2021. The i-Nov Innovation Competition is funded by the State via the Future Investments Program (PIA) and operated by Bpifrance and l & #039; ADEME.

[REPLAY WEBINAR] Innovation competition: Maximize your chances of success!

The i-Nov Innovation Competition is funded by the State via the Future Investments Program (PIA) and operated by Bpifrance and ADEME. It supports the accelerated emergence of companies (start-ups and SMEs) with the potential to become world-class leaders in their field. For the winners, this is an opportunity to obtain co-financing (up to 45%) of their

Financing adapted to the resumption of growth

Financing adapted to restarting growth [White Paper]

“In order to promote the development and sustainable growth of companies, many levers exist to accelerate their innovative projects. In this white paper, you will discover how to reconcile tax systems to support innovation, public aid and subsidies and sources of private funding and how these levers can be articulated to bring out your projects,

Keep in touch !Subscribe to the newsletter


* Please fill in the required fields.

In accordance with the provisions of the regulations on the protection of personal data, GAC, as data controller, processes your data in order to respond to your request related to GAC products and services.
In accordance with the regulations in force, you have the right to access, rectify, delete and oppose your personal data. You can assert these rights by contacting our DPO at: and by proving your identity. You can also lodge a complaint with the CNIL. Learn more.

Scroll to Top